The global foot insoles market to grow at a CAGR of 6.64% during the period 2017-2021.
The report covers the present scenario and the growth prospects of the global foot insoles market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of foot insoles.
Shoes are not just a significant part of clothing because of style, but they also provide relief and support in the right places. A wrong pair of shoes can cause shin, back, knee, or even hip pain if not properly supported. Most vendors of sports footwear are focusing on customization. Retailers, like Amazon, have been harvesting recurring gains from doing so for their vast consumer base using Big Data. Vendors are progressively concentrating on providing consumers with customized products, thereby, uplifting customer loyalty and engagement.
According to the report, dwindling birth rates have led to a rise in the population of older people. For instance, in Japan where people aged 65 years and above currently contribute to 23%-25% of the population, the percentage is expected to reach 38% by 2050. In North America, the estimates are between 13% and 22%, and in Europe, they are between 16% and 27%.
- Bayer HealthCare
Other Prominent Vendors:
- Spenco Medical
- ING Corporation
- SOLO Laboratories
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Market segmentation by application
Part 07: Market segmentation by material type
Part 08: Geographical segmentation
Part 09: Market drivers
Part 10: Impact of drivers
Part 11: Market challenges
Part 12: Impact of drivers and challenges
Part 13: Market trends
Part 14: Vendor landscape
Part 15: Key Vendor Analysis
Part 16: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/xw3zlc/global_foot.